Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
Benitec Biopharma is a clinical-stage biotechnology company developing genetic medicines using its ddRNAi platform, which combines RNA interference with gene therapy to silence disease-causing genes through a single administration. It develops therapeutics for chronic and life-threatening conditions, including Oculopharyngeal Muscular Dystrophy (OPMD).
0 investors
0 investors
Iterion Therapeutics is a clinical-stage biopharmaceutical company developing Tegavivint, a Wnt/β-catenin pathway inhibitor targeting TBL1, for cancers driven by Wnt mutations. Its lead focus is advanced hepatocellular carcinoma, with expansion into other Wnt-driven tumors such as colorectal cancer.
0 investors
0 investors
Beyond Air develops medical devices for respiratory treatment, serving healthcare providers and patients.
0 investors
0 investors
BG Medicine develops and commercializes cardiovascular diagnostic tests to assess heart failure risk and predict cardiovascular events. The company serves patients and healthcare providers seeking to improve diagnostic accuracy and patient outcomes in cardiology.
0 investors
0 investors
0 investors
0 investors
0 investors
Bio Essence Corp is a US-based, publicly traded (OTC Pink: BIOE) biotechnology company that develops holistic wellness and supplement products and operates in-person clinics for patient care. It serves healthcare practitioners and patients, working with an in-house R&D team and a medical advisory board of healthcare professionals.
0 investors
Bio Usawa is a biotechnology company that develops and manufactures affordable monoclonal antibodies and biologic medicines, with a focus on bringing cancer and other therapies to patients in Africa and globally.
0 investors
0 investors
0 investors
0 investors
Bio-Path Holdings is a clinical-stage biotechnology company developing antisense RNAi nanoparticle drugs as targeted, lower-toxicity cancer therapies for fragile patients ineligible for high-dose chemotherapy. Its pipeline targets blood cancers such as acute myeloid leukemia and lymphoma as well as solid tumors.
0 investors
0 investors
0 investors
BioAegis Therapeutics is a clinical-stage biotech developing therapies for infectious and non-infectious inflammatory diseases based on a recombinant human form of plasma gelsolin (rhu-pGSN), a blood protein that regulates the immune response. Its platform aims to restore depleted gelsolin levels to control inflammation without suppressing immune function.
0 investors
bioAffinity Technologies develops noninvasive laboratory diagnostic tests that use flow cytometry and machine learning analysis to detect early-stage lung cancer and other lung diseases from sputum samples. The company's lead product, CyPath® Lung, is offered through its subsidiary PPLS, a CAP-accredited clinical laboratory, and serves physicians evaluating patients at high risk for lung cancer.
0 investors
0 investors
BioCardia develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, with a lead program targeting ischemic heart failure with reduced ejection fraction. Its work centers on autologous cell therapy delivered through clinical trials.
0 investors
0 investors